Sumatriptan and Pomalyst drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sumatriptan (sumatriptan succinate) and Pomalyst (pomalidomide). Common drug interactions include dyspepsia among females and neuropathy peripheral among males.

The phase IV clinical study analyzes what interactions people have when they take Sumatriptan and Pomalyst. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Sumatriptan?

Sumatriptan has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 18,159 Sumatriptan users. Check the latest studies of Sumatriptan.

What is Pomalyst?

Pomalyst has active ingredients of pomalidomide. eHealthMe is studying from 80,400 Pomalyst users. Check the latest studies of Pomalyst.

On Jul, 06, 2026

31 people who take Sumatriptan and Pomalyst together, and have interactions are studied.

Sumatriptan and Pomalyst drug interactions.

What are the common drug interactions of Sumatriptan and Pomalyst, by gender? *:

female:

Dyspepsia (indigestion)
White blood cell count decreased
Fatigue (feeling of tiredness)
Insomnia (sleeplessness)
Nausea (feeling of having an urge to vomit)
Blood potassium decreased
Bowel movement irregularity
Diarrhoea
Nasopharyngitis (inflammation of the nasopharynx)
Rash

male:

Neuropathy peripheral (surface nerve damage)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Constipation
Dry eye (lack of adequate tears)
Erectile dysfunction
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Muscle spasms (muscle contraction)
Gingivitis (inflammation of gums)
Arthralgia (joint pain)
Bowel movement irregularity

What are the common drug interactions of Sumatriptan and Pomalyst, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Dyspepsia (indigestion)
Fatigue (feeling of tiredness)
Insomnia (sleeplessness)
Nausea (feeling of having an urge to vomit)
White blood cell count decreased
Blood potassium decreased
Bowel movement irregularity
Diarrhoea
Vomiting
Abdominal pain upper

50-59:

Completed suicide (act of taking one's own life)

60+:

Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Muscle spasms (muscle contraction)
Sneezing
Nasopharyngitis (inflammation of the nasopharynx)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
White blood cell count decreased
Death
Disease progression
Febrile neutropenia (fever with reduced white blood cells)
Rash

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 29 people, 93.55%

* Approximation only. Some reports may have incomplete information.

Do you take Sumatriptan and Pomalyst?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously